TH1601002081A - Pharmaceutical form comprising sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazole-1-yl)-1H -pyrazole-5-oleate - Google Patents

Pharmaceutical form comprising sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazole-1-yl)-1H -pyrazole-5-oleate

Info

Publication number
TH1601002081A
TH1601002081A TH1601002081A TH1601002081A TH1601002081A TH 1601002081 A TH1601002081 A TH 1601002081A TH 1601002081 A TH1601002081 A TH 1601002081A TH 1601002081 A TH1601002081 A TH 1601002081A TH 1601002081 A TH1601002081 A TH 1601002081A
Authority
TH
Thailand
Prior art keywords
morpholin
pyrimidin
pyrazole
triazole
oleate
Prior art date
Application number
TH1601002081A
Other languages
Thai (th)
Other versions
TH166468A (en
TH166468B (en
Inventor
ไฮเคอ นอยมันน์ดร เคลาส์ เบนเคอนายไมเคิล ฟอร์เมลล์ดร กาเบรียล วินเทอร์ ดร
Original Assignee
เบเยอร์ ฟาร์มา อัคเตียนเกเซลล์ชาฟท์
Filing date
Publication date
Application filed by เบเยอร์ ฟาร์มา อัคเตียนเกเซลล์ชาฟท์ filed Critical เบเยอร์ ฟาร์มา อัคเตียนเกเซลล์ชาฟท์
Publication of TH166468A publication Critical patent/TH166468A/en
Publication of TH166468B publication Critical patent/TH166468B/en
Publication of TH1601002081A publication Critical patent/TH1601002081A/en

Links

TH1601002081A 2014-10-13 Pharmaceutical form comprising sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazole-1-yl)-1H -pyrazole-5-oleate TH1601002081A (en)

Publications (3)

Publication Number Publication Date
TH166468A TH166468A (en) 2017-08-24
TH166468B TH166468B (en) 2017-08-24
TH1601002081A true TH1601002081A (en) 2017-08-24

Family

ID=

Similar Documents

Publication Publication Date Title
IL257282B (en) 2-(4-aminocyclohexylamino)-4-(pyrazol-4-yl)pyrimidine compounds
HK1253048A1 (en) 1, 4-substituted piperidine derivatives
HK1248070A1 (en) Heterocyclic compounds as kinase inhbitors
EP3376865A4 (en) 4-((6-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h
HK1248226A1 (en) 1,4-di-substituted imidazole derivative
IL247728B (en) 1- (3,5-disubstituted-pyridin-4-yl) - piperidines
DK3395342T3 (en) Tablet comprising 1- (3- (2- (1-benzothiophen-5-YL) ethoxy) propyl) azetidin-3-ol or salt thereof
IL267303B (en) Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
IL243650A0 (en) 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
EP3150587A4 (en) Deuterium substituted 1-[2-(2,4-dimethyl-thiophenyl)-phenyl]piperazine compound or derivative thereof, and pharmaceutical composition and use thereof
IL252986A0 (en) 3,5-diaminopyrazole kinase inhibitors
ITUA20162992A1 (en) MACHINE FOR POCKETS APPLICATION.
DK2915526T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANAGRELID
ZA201801544B (en) 1-(4-(2-((1-(3,4-difluorophenyl)-1h-pyrazol-3-yl)methoxy)ethyl) piperazin-1-yl)ethanone salts
TH1601002081A (en) Pharmaceutical form comprising sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazole-1-yl)-1H -pyrazole-5-oleate
IL244933B (en) Pharmaceutical dosage forms containing sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-olate
DK3389638T3 (en) PHARMACEUTICAL COMPOSITION COMPRISING PIMOBENDAN
DK3424500T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING FAMITINIB
ITUA20162998A1 (en) 180 ° hinge.
ITUB20153493A1 (en) EQUIPMENT FOR STUDIES APPLICATION.
IT201700024657A1 (en) MATTRESS FOR SURGICAL OPERATIONS.
TH1601000345A (en) Derivative 1-(piperacin-1-yl)-2-([1,2,4]triazole-1-yl)-ethanone
TH1501002647A (en) Formulated with Pluronic F127 and methyl cellulose. for bone formation
UA32520S (en) CORNER SOFA "SEATLE"
PL2988083T3 (en) Adjustable wardrobe